Virtus NFJ Small-Cap Value Fund Class A
PCVAX
NASDAQ
| Weiss Ratings | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Virtus | |||
| Manager/Tenure (Years) | Paul A. Magnuson (29), John R. Mowrey (12), Jeff N Reed (7), 2 others | |||
| Website | http://www.virtus.com | |||
| Fund Information | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Virtus NFJ Small-Cap Value Fund Class A | |||
| Category | Small Value | |||
| Sub-Category | US Equity Small Cap | |||
| Prospectus Objective | Small Company | |||
| Inception Date | Jan 20, 1997 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.45% | |||
| Dividend | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.70% | |||
| Asset Allocation | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.78% | |||
| Stock | 99.22% | |||
| U.S. Stock | 97.47% | |||
| Non-U.S. Stock | 1.75% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.27% | |||
| 30-Day Total Return | 3.66% | |||
| 60-Day Total Return | -5.28% | |||
| 90-Day Total Return | -8.65% | |||
| Year to Date Total Return | -10.10% | |||
| 1-Year Total Return | -3.06% | |||
| 2-Year Total Return | 16.05% | |||
| 3-Year Total Return | 14.05% | |||
| 5-Year Total Return | 59.04% | |||
| Price | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $10.76 | |||
| 1-Month Low NAV | $10.49 | |||
| 1-Month High NAV | $11.24 | |||
| 52-Week Low NAV | $9.56 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $13.76 | |||
| 52-Week High Price (Date) | Nov 25, 2024 | |||
| Beta / Standard Deviation | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.23 | |||
| Standard Deviation | 23.74 | |||
| Balance Sheet | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 246.96M | |||
| Operating Ratios | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.17% | |||
| Turnover Ratio | 60.00% | |||
| Performance | PCVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 22.26% | |||
| Last Bear Market Total Return | -11.60% | |||